C3 and skin neoplasm: Consistent with other reports (Bonavita et al., 2015; Riihilä et al., 2017), we found in both human and mouse skin tumors an abundance of C3 activation products, specifically C3d, presumably marking cells ready for disposal by mononuclear phagocytes.